This inventor holds 1 USPTO granted patent. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jan Hillson: Innovator in Antibody Research
Introduction
Jan Hillson is a notable inventor recognized for his contributions to the field of biotechnology. He has made significant strides in the development of FcRn antibodies, which have important applications in various medical treatments. His work is instrumental in advancing therapeutic options for patients.
Latest Patents
Jan Hillson holds a patent for "FcRn Antibodies and Methods of Use Thereof." This patent highlights his innovative approach to utilizing antibodies in therapeutic applications, showcasing his expertise in the field.
Career Highlights
Jan Hillson is currently associated with Momenta Pharmaceuticals, Inc., where he continues to contribute to groundbreaking research and development. His role at the company allows him to work on cutting-edge projects that aim to improve patient outcomes through innovative therapies.
Conclusion
Jan Hillson's work in antibody research exemplifies the impact of innovation in biotechnology. His patent and ongoing contributions at Momenta Pharmaceuticals, Inc. reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
